Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myosin heavy chain 15 is a protein encoded by the MYH15 gene in humans. It is a member of the myosin superfamily, specifically a sarcomeric myosin heavy chain isoform. MYH15 acts as a slow-twitch myosin and is found primarily in skeletal muscle, heart, and various brain regions, where it fulfills roles in muscle contraction and cytoskeletal architecture through actin binding and ATP-dependent motor activity[1][2][3][5]. Variants in MYH15 have been associated with genetic disorders involving neuromuscular and cognitive deficits, such as progressive microcephaly with seizures and autosomal recessive deafness[2][4]. The role of MYH15 appears essential for proper muscle development and overall muscle function, though detailed molecular mechanisms remain under active investigation[4][6]. MYH15 is not currently considered a direct therapeutic target, and no specific drugs or targeted modulators of this protein are available in clinical use[2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myosin heavy chain 15 (MYH15).